跳至主要内容
临床试验/NCT03131622
NCT03131622Unknown不适用

Impact of Ibis, a Digital Health Solution for Patient Activation and Early Intervention, on Acute Care Utilization by Patients With Advanced COPD

Senscio Systems0 个研究点目标入组 240 人开始时间: 2016年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
240
主要终点
Reduction in Acute Care Utilization

研究概览

简要总结

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients with COPD.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •Gold Stage II with a CAT Score above 19
  • •Gold Stage III/IV with a CAT Score above 14

排除标准

  • •Cognitive or physical impediments that inhibits patients from interacting with our digital therapeutics platform.

研究组 & 干预措施

Digital Therapeutics

Experimental

Patients assigned to the digital therapeutics arm will receive Ibis and all the associate services.

干预措施: Digital Therapeutics (Behavioral)

Control

No Intervention

结局指标

主要结局

Reduction in Acute Care Utilization

时间窗: 6 months and then again at 1 year

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验